New data from a study conducted by Eurofins Discovery Phenotypic Center of Excellence comparing the biological activities of MyMD’s lead compound MYMD-1 with leading TNF inhibitors.

View More

Back to All News

  • This field is for validation purposes and should be left unchanged.